|
|
||||||||||||||
|
|
|||||||||||||||
| The first 150 words of the full text of this article appear below. |
The purpose and procedure section in each issue of Evidence-Based Medicine describes the criteria for selecting articles for inclusion. The journals read are also listed at http://bmjupdates.mcmaster.ca/journalslist.asp. All articles that meet our criteria in the reviewed journals are cited in Evidence-Based Medicine, but there is not enough space to abstract them all. The following articles passed all criteria but were not abstracted. Practising clinicians rated them for clinical relevance and newsworthiness, and the mean scores are displayed. A fuller list of articles and a sample of the rating form are available on the Evidence-Based Medicine web site (www.evidence-basedmedicine.com/cgi/content/full/12/5/e1).
THERAPEUTICS
Adi Y, Juarez-Garcia A, Wang D, et al. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. Health Technol Assess 2007;11:1–85.[Medline]
GP/FP/Mental health 





Psychiatry 





Ashton HA, Gao L, Kim LG, et
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |